المؤلفون: Kirsten Evans, Adel Eltantawy, Ximena Vallejos, Elrodia Sebea

المصدر: Annals of Pharmacotherapy. 53:954-958

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, medicine.medical_treatment, Follicular lymphoma, Angiogenesis Inhibitors, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Recurrence, Internal medicine, medicine, Humans, Pharmacology (medical), Adverse effect, Lymphoma, Follicular, PI3K/AKT/mTOR pathway, Aged, Phosphoinositide-3 Kinase Inhibitors, 030304 developmental biology, Copanlisib, 0303 health sciences, Chemotherapy, Hematology, Kinase, business.industry, Middle Aged, medicine.disease, Lymphoma, Pyrimidines, chemistry, 030220 oncology & carcinogenesis, Quinazolines, Administration, Intravenous, Female, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475a6c49b71d96f1f8a12fe51cc1eb94
https://doi.org/10.1177/1060028019833992